While INTERACT2 showed no significant difference in the risk of poor outcome or 90-day mortality among patients with a target SBP less than 140 mmHg following ICH, there was a clear trend toward benefit, including a statistically significant reduction in disability.[ 14 ] ATACH-2 showed that reducing SBP further to a target of 110–139 mmHg had no impact on the rate of death or disability.[ 15 ] Across both trials, achieving the target SBP during the first 24 h resulted in improved f
← all excerpts
Acute Spontaneous Intracerebral Hemorrhage Management Update: Five New Things You Should Know.
1
—
—